FAS -670A>G genetic polymorphism Is associated with treatment resistant depression

Hippocampal neurogenesis has been suggested as a downstream event of antidepressants (AD) mechanism of action and might explain the lag time between AD administration and the therapeutic effect. Despite the widespread use of AD in the context of Major Depressive Disorder (MDD) there are no reliable...

ver descrição completa

Detalhes bibliográficos
Autor principal: Santos, Marlene (author)
Outros Autores: Carvalho, Serafim (author), Lima, Luís (author), Mota-Pereira, Jorge (author), Pimentel, Paulo (author), Maia, Dulce (author), Correia, Diana (author), Gomes, Sofia (author), Cruz, Agostinho (author), Medeiros, Rui (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
Neurogenesis
Neuroplasticity
FAS
Antidepressants
Treatment resistant depression
Polymorphisms
Texto completo:http://hdl.handle.net/10400.22/18918
País:Portugal
Oai:oai:recipp.ipp.pt:10400.22/18918

Texto Completo

http://hdl.handle.net/10400.22/18918

Registros relacionados